Echocardiography in Metabolic Syndrome: Monitoring and Management (PDF)

Echocardiography in Metabolic Syndrome: Monitoring and Management (PDF Book)

By David Maisuradze, Alexandre Qistauri
Metabolic syndrome (MetS) is a serious health condition that puts people at a higher risk of heart disease, diabetes, stroke, and atherosclerosis. Prevalent worldwide, MetS-related induced mortality and frequency contributes to the progression of heart failure, which can be controlled by proper treatment. This book identifies the echocardiographic characteristics that undergo changes in MetS, significantly affecting its course, and contributing to the clinical aggravation of the disease. This linking with echocardiography as a marker of heart failure due to MetS is useful for academics and professionals in Cardiology, Endocrinology, and Internal Medicine for effective management.

By David Maisuradze and Alexandre Qistauri, “Metabolic Syndrome and Echocardiographic Characteristics: Understanding the Link and Effective Management” delves into the serious health condition known as metabolic syndrome (MetS) and its impact on heart disease, diabetes, stroke, and atherosclerosis. With its prevalence worldwide, MetS not only contributes to increased mortality rates but also plays a significant role in the progression of heart failure. However, with proper treatment and the identification of echocardiographic characteristics that undergo changes in MetS, there is hope for effective management and control of the disease.

This groundbreaking book uncovers the intricate relationship between MetS and echocardiography, shedding light on how changes in echocardiographic characteristics can shape the course of the condition and worsen its clinical outcomes. It serves as a valuable resource for academics and professionals in the fields of Cardiology, Endocrinology, and Internal Medicine, equipping them with the knowledge and tools necessary to effectively manage MetS-induced heart failure.